milnacipran has been researched along with Long QT Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikawa, M; Yamada, K | 1 |
| Adachi-Akahane, S; Hoshiai, K; Koizumi, S; Matsumoto, M; Mitsumori, Y; Nagayama, Y; Nakamura, Y; Sugiyama, A | 1 |
2 other study(ies) available for milnacipran and Long QT Syndrome
| Article | Year |
|---|---|
Effectiveness of milnacipran for a patient with pain disorder and long QT syndrome.
Topics: Adult; Antidepressive Agents, Tricyclic; Contraindications; Cyclopropanes; Drugs, Investigational; Facial Pain; Female; Humans; Long QT Syndrome; Milnacipran; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome | 2010 |
In vivo canine model comparison of cardiovascular effects of antidepressants milnacipran and imipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Tricyclic; Cyclopropanes; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Hemodynamics; Imipramine; Infusions, Intravenous; Long QT Syndrome; Male; Milnacipran; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Time Factors; Ventricular Function | 2010 |